赛默飞世尔将以 41 亿美元收购 Solventum 的纯化和过滤业务

路透中文
25 Feb
<a href="https://laohu8.com/S/TMO">赛默飞世尔</a>将以 41 亿美元收购 <a href="https://laohu8.com/S/SOLV">Solventum</a> 的纯化和过滤业务

路透社2月25日 - 合同药品生产商赛默飞世尔科技公司TMO.N周二表示,将以约41亿美元现金收购Solventum公司SOLV.N的纯化和过滤业务。

交易预计将于2025年底完成。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10